Quantcast

Latest drug discovery Stories

2014-09-17 12:27:05

New multi-year grant furthers non-profit organization's work to accelerate the drug development process TUCSON, Ariz., Sept. 17, 2014 /PRNewswire-USNewswire/ -- The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has awarded the organization $2.1 million in first year funding of a five-year grant with the potential of $10.5 million over the five years. This is the second five-year grant that C-Path has received from the FDA under the...

2014-09-16 23:11:40

Achieve Clinical Research is looking for adults who have never have not been vaccinated for pneumonia within the last year to take part in this new clinical study. Applicants should be at least 18 years old in order to qualify for a clinical trial here in Birmingham. Birmingham, Alabama (PRWEB) September 16, 2014 *To find out more about this pneumonia vaccine clinical trial in Birmingham, AL, visit Achieve Clinical Research on the web...

2014-09-16 12:30:26

BOSTON, September 16, 2014 /PRNewswire/ -- Russia's pharmaceutical market has been growing faster over recent years. The Pharma 2020 Strategy provides incentives for local producers to develop original and generic drugs for both domestic and foreign markets. These trends, however, were affected by recent developments connected with the political situation and the following political and economic sanctions imposed on Russia. (Logo:...

2014-09-16 04:21:23

LONDON and BOSTON, September 16, 2014 /PRNewswire/ -- Heptares Therapeutics notes that its Chief Scientific Officer, Fiona Marshall, will give a presentation entitled "Structure-based Drug Design for G protein-coupled receptors using StaR(R) technology" as part of the inaugural "Advances in Drug Discovery and Development" virtual symposium run by Chemical & Engineering News, a publication of the American Chemical Society. The virtual symposium is on Wednesday, 24 September...

2014-09-15 08:29:50

SPRINGFIELD, N.J., Sept. 15, 2014 /PRNewswire/ -- Hudson Robotics, Inc., of Springfield, NJ, in cooperation with Johns Hopkins University, has recently been awarded an NIH grant to develop a commercially viable high-throughput screening (HTS) system for in vivo studies of zebrafish. Logo - http://photos.prnewswire.com/prnh/20140912/145910 This system, termed the Automated Reporter Quantification in vivo (ARQiv) system, will bring high-throughput screening technology into the realm...

2014-09-12 08:25:44

SARASOTA, Fla., Sept. 12, 2014 /PRNewswire/ -- Rock Creek Pharmaceuticals, Inc., (NASDAQ: RCPI), a drug development company focused on chronic inflammatory disease and neurologic disorders, announced today it has received a written response from the U.S. Food and Drug Administration (FDA) in response to the New Dietary Ingredient Notification (NDIN) for the formulations of Anatabloc® and CigRx® submitted by the Company in June 2014. The letter indicated that the FDA considers...

2014-09-10 12:27:57

NEW YORK, Sept. 10, 2014 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and OnDeckBiotech announced today the launch of ADDF ACCESS, a new and improved open access platform to connect scientists with a virtual network of contract research organizations (CROs), drug development experts and educational resources. By leveraging OnDeckBiotech's cutting-edge technology, the enhanced ADDF ACCESS platform will streamline links between researchers and CROs specializing...

2014-09-10 08:32:36

- Findings and research approach published in Nature Communications - CAMBRIDGE, Mass., Sept. 10, 2014 /PRNewswire/ -- Blueprint Medicines, a leader in discovering and developing highly selective kinase inhibitors for genomically defined cancers, today announced the identification of several new cancer drug targets known as fusion genes. These findings were made through a proprietary computational approach and led to two new drug discovery programs at Blueprint Medicines. Blueprint Medicines'...

2014-09-09 12:29:48

DUBLIN, Sept. 9, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Drug Discovery Technologies - A Global Market Overview" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 The development of new drugs for treating difficult diseases, such as cancer requires extensive expenditure, in addition to consuming a lot of time. The first step in designing a new drug involves the utilizing high-throughput screening of large chemical libraries for...

2014-09-09 12:29:19

MENLO PARK, Calif., Sept. 9, 2014 /PRNewswire/ -- SRI International, an independent nonprofit research institute, and Nobelpharma, a Japanese pharmaceutical company, have entered into a licensing agreement to test SR16234, an SRI drug candidate that may be effective in treating endometriosis. SR16234 is a member of a class of drugs known as selective estrogen receptor modulators (SERMs) that regulate the effects of the hormone estrogen. "This important collaboration is addressing a...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.